Dow vs LyondellBasell: The Cash Flow Divide That Makes This an Easy Choice

Key takeaways

• Both Dow and LyondellBasell are bleeding earnings in a deep chemicals cycle, but their cash-flow trajectories are heading in opposite directions.
• Dow beat Q1 2026 estimates despite the sector downturn, while LyondellBasell slashed its dividend nearly in half - a signal the board no longer trusts the near-term cash outlook.
• On valuation, the two trade at nearly identical EV/EBITDA multiples. But Dow's balance sheet, improving FCF trend, and more sustainable dividend make it the cleaner risk.
• I rate Dow a Buy. LyondellBasell is a Hold at current levels.

One of the more tempting comparisons in the chemicals space right now pits Dow against LyondellBasell. Both are trading at depressed multiples, both are paying attractive-looking yields, and both are caught in the same industry-wide pricing and demand squeeze. A headline comparison of market cap or dividend yield could make them look like interchangeable plays on a chemicals recovery. But when you walk through the cash-flow data, the two companies are in fundamentally different places.

Let me start with the cash.

Dow generated $2.07 billion in operating cash flow over the trailing twelve months. Capital expenditures ran $2.45 billion, leaving free cash flow at negative $389 million. That negative number is the first reason investors hesitate. But it is improving - free cash flow grew 32% year-over-year, meaning the cash burn is narrowing. In Q1 2026 alone, Dow produced $1.12 billion in operating cash flow while posting an adjusted loss of just $0.14 per share, which beat the consensus estimate of -$0.29 by more than 50%. The loss is real, but the narrowing is the story.

LyondellBasell looks better on the surface. It generated $908 million in free cash flow over the trailing twelve months - a positive number, versus Dow's deficit. Operating cash flow hit $2.57 billion. But that free cash flow figure represents a 40% year-over-year decline. And the board's response to deteriorating cash tells you everything about management's confidence: in February 2026, LyondellBasell cut its quarterly dividend from $1.37 to $0.69 per share - a reduction of roughly 50%. That is not a cosmetic adjustment. That is a board telling shareholders that the cash runway has shortened.

From a balance-sheet perspective, the gap widens further. Dow carries $43 billion in total debt against $16.76 billion in equity, for a debt-to-equity ratio of 108%. But with $4.11 billion in cash, net debt works out to $14 billion - roughly 0.4 times enterprise value, and manageable relative to the $2.07 billion annual operating cash flow. LyondellBasell has less absolute debt at $23.79 billion, but its equity base is only $10.16 billion, pushing debt-to-equity to 127%. Net debt stands at $10.29 billion. Neither balance sheet is in crisis mode, but Dow's is more durable - lower leverage relative to equity, and a cash-flow trajectory that is improving rather than collapsing.

Now let's talk about the dividend, because this is where the cheap-yield trap materializes for LyondellBasell. Dow yields 4.6%, with a forward yield of roughly 4.6% on its $1.39 per share trailing dividend. The payout ratio is negative - an accounting artifact of current-year losses - but on an operating-cash-flow basis, the roughly $1.0 billion annualized dividend is about 49% of the $2.07 billion in operating cash. That is a comfortable coverage level.

LyondellBasell's forward yield looks much more attractive at 9.4% on the new $0.69 quarterly dividend. But a 9% yield on a company whose free cash flow fell 40% and whose board just halved the payout is a yield that earned itself by deteriorating, not by discounting. Annualized at the new rate, the dividend is about $2.76 per share, or roughly $891 million on approximately 323 million outstanding shares. That still requires about 98% of current trailing free cash flow just for dividends, with nothing left for debt reduction or growth. Even if the dividend is safe at the new level for now, the margin for error is thin. A further softening in polyethylene or olefins pricing - the products that have been dragging margins across the sector - would force another difficult conversation.

Valuation does not separate the two stories. Dow trades at 23.3 times EV/EBITDA against LyondellBasell's 25.9 times. Both are expensive by historical standards for cyclical chemical companies - a reflection of the earnings trough, not a judgment on intrinsic value. On price-to-book, Dow is the cheaper name at 1.3x versus LyondellBasell's 1.86x. On price-to-sales, Dow runs at 0.56x compared to LyondellBasell's 0.64x. The market has not meaningfully differentiated these two names on multiples, even though the underlying cash-flow and balance-sheet stories are diverging.

While it's true that both companies are exposed to the same macro headwinds - weak end-market demand, soft commodity prices, and a sector-wide margin squeeze - the companies are responding differently. Dow's Q1 2026 beat, despite revenue down roughly 6% year-over-year to $9.79 billion, shows that cost discipline is translating into earnings protection. LyondellBasell's management delivered $800 million from its Cash Improvement Plan in 2025, well above the $600 million target, but the dividend cut that followed signals that even best-case execution is not enough to sustain prior payout levels.

Even if the chemicals sector turns before either company's next earnings report - Dow reports on July 23rd, LyondellBasell on July 31st - the structural advantage belongs to Dow. A recovery lifts both names, but Dow enters that recovery with improving cash flows, a more sustainable dividend, and a balance sheet that does not require a payout reset to stay viable.

This does not mean LyondellBasell is broken. The company has $2.6 billion in cash on hand and genuine cost-improvement discipline. But value investing is not just about buying the highest yield. It is about buying cash-flow durability at a discount with a margin of safety. On that test, Dow passes more comfortably.

All things considered, Dow remains attractively priced relative to its improving cash-flow trajectory and balance-sheet quality. I rate it a Buy. LyondellBasell, after the dividend cut and with free cash flow in steep decline, is not the bargain the headline yield suggests. I rate it a Hold until the cash-flow trend stabilizes and management can demonstrate that the new dividend level is sustainably covered.